Oligonucleotide DNA microarray analyses

AB Anna Berg
AG Ankush Gulati
SY Sigmund Ytre-Hauge
KF Kristine E. Fasmer
KM Karen K. Mauland
EH Erling A. Hoivik
JH Jenny A. Husby
IT Ingvild L. Tangen
JT Jone Trovik
MH Mari K. Halle
IS Ingunn Stefansson
LA Lars A. Akslen
KW Kathrine Woie
LB Line Bjørge
HS Helga B. Salvesen
ØS Øyvind O. Salvesen
HW Henrica M.J. Werner
IH Ingfrid S. Haldorsen
CK Camilla Krakstad
request Request a Protocol
ask Ask a question
Favorite

RNA was extracted from fresh frozen tumor tissue in the area of highest tumor purity. The bulk of samples had tumor content above 80%, and the minimum inclusion threshold was set to >50%. The RNA was hybridized to Agilent Whole Human Genome Microarrays according to instruction from the vendor (www.agilent.com). The arrays were then scanned by the Agilent Microarray Scanner Bundle. Intensity of the spot signal was interpreted by using the software J-Express (http://jexpress.bioinfo.no/site/).

Samples diagnosed by pathologist as CAH or EECG1 were selected, and unsupervised hierarchical clustering was conducted using Euclidean distance measurement. Transcriptional differences between two groups were explored by GSEA [17], applying pre-defined gene sets supplied by the MSigDB (www.broadinstitute.org/gsea/index.jsp). SAM was used to identify genes most differentially expressed in two groups of patients.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A